“ "Poland must move towards having a more patient-centric approach of healthcare, and we want to be part of this movement." ”
In Conversation
Interview: Petra Exner – Managing Director DACH; Tobias Haber – Managing Director, INSIGHT Health Switzerland
“ "We should be very established in Switzerland and Austria soon and work with new solutions and satisfied customers." ”
“ "Based on our experience, the most prevalent disease types are within the oncology and cardiology therapeutic areas." ”
Interview: Bogna Cichowska – Duma General Director, Employers’ Association of Innovative Pharmaceutical Companies (INFARMA), Poland
“ "Poland remains the largest clinical trials market in CEE – however - both patient participation and site penetration rates indicate a potential for growth." ”
“ "Overall, we want to create a more stable system that does not fluctuate so rapidly; therefore, the reimbursement list will be launched each quarter, rather than… ”
“ "Implementing digitalization and e-health is a challenge in Bulgaria as politicians needs to take actions in this regard." ”
Interview: Mirosław Zieliński – President National Forum for the Therapy of Rare Diseases (ORPHAN), Poland
“ "The national program has been developed based on the initial model designed by the European project for rare disease plans." ”
“ "The company´s focus is Email and Web security, and in today’s environment this must be done in layers, an approach called “defence in depth”." ”
“ "Our business in Bulgaria is quite well defined in three main pillars: diabetic and its complications, cardiovascular, and integral pain management." ”
Interview: Vladimir Afenliev – Chief Director Business Operations, Strategic and Organizational Developments at Sopharma, Bulgaria
“ "It is important to remember that Sopharma is a modern pharmaceutical manufacturer in Bulgaria, not necessarily big in size but strong in content." ”
“ "As a member of the Bulgarian Generics Pharmaceutical Association (BGPharmA), Mylan is working on establishing a sustainable and predictable healthcare environment." ”
Interview: Gerhard Hirczi – Managing Director, Vienna Business Agency; Peter Halwachs – Managing Director, LISAvienna
“ "The time has come for the international community to reevaluate Vienna’s role in the pharmaceuticals and life sciences landscape." ”